Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study.
about
In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7Clinical and neuroradiological features of spinocerebellar ataxia 38 (SCA38)Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis.Discriminating sample groups with multi-way data.Morphometric study on dimensions of various parts of pons and comparison of data in accordance with age and sex of healthy people by MRI.Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status.Diffusion tensor imaging of spinocerebellar ataxia type 12.Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy.Progression of brain atrophy in spinocerebellar ataxia type 2: a longitudinal tensor-based morphometry study.Extensive White Matter Alterations and Its Correlations with Ataxia Severity in SCA 2 PatientsA longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7Impact of cerebellar atrophy on cortical gray matter and cerebellar peduncles as assessed by voxel-based morphometry and high angular resolution diffusion imaging.Magnetic resonance imaging biomarkers in patients with progressive ataxia: current status and future direction.From pathways to targets: understanding the mechanisms behind polyglutamine disease.Modifications of resting state networks in spinocerebellar ataxia type 2.The Multiple Faces of Spinocerebellar Ataxia type 2.Spinocerebellar ataxia type 12 identified in two Italian families may mimic sporadic ataxia.Loss of intrinsic organization of cerebellar networks in spinocerebellar ataxia type 1: correlates with disease severity and duration.Supratentorial and infratentorial damage in spinocerebellar ataxia 2: a diffusion-weighted MRI study.Genetics of ataxias: hereditary forms.Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.Diffusion tensor imaging of spinocerebellar ataxias types 1 and 2.Adaptation to visuomotor rotation and force field perturbation is correlated to different brain areas in patients with cerebellar degeneration.Early impairment in brain metabolism detected by MR spectroscopy antedates structural changes in mouse models of spinocerebellar ataxias.Metabolic evidence for cerebral neurodegeneration in spinocerebellar ataxia type 1.Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2.Current molecular insight to reveal the dynamics of CAG repeating units in spinocerebellar ataxia.Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes.
P2860
Q28391815-D9C93FEF-03DC-42C6-A221-DB7DF11BA5DCQ30379273-3A96B48E-8CA6-4131-874E-37FD4F511028Q31001850-FE663F58-F694-4F78-AA33-7DB406EFB225Q31156245-2D79D491-B071-4169-AEBF-08B46D971F3CQ33421145-DFB2383C-5E19-422E-8A58-DA5EF9596D77Q34046625-6D0AD339-FFA9-4FEA-B6EF-B3DD9E60DA95Q34350278-1FF6DC9A-623B-475D-A7C1-32E02CC97F65Q34456340-708FEC2A-F583-45B5-9CDB-A18F2EDF9CAFQ34951012-7A945E67-FF6B-4B2F-985A-C16F3814976BQ35107256-0D01E2EC-8E0E-42F1-9D14-7B42BB00DA93Q35742643-3D088FF4-EE64-4817-9CD9-8DD1D301C3F4Q37030997-0CC1C2C7-5F73-4374-8297-E7F437649732Q37583233-166AA653-66B6-4ECB-AF33-F39E16C036FFQ38029255-C8EF105E-E649-418F-B42F-D02230237F91Q38259591-367E9E90-0230-40F2-B398-CF623DC7548CQ40816109-97976DD5-6F23-461B-9760-85BE3C3F9E31Q41510206-EB8CCFEB-EF08-47CC-B564-E1CFA980872BQ42668081-889B55A1-2534-430F-BF9D-5BC100A2A679Q42731417-EBDD1AB0-6A99-4B6B-BB8D-A2B7A6B1AC90Q45394861-209998FA-A41D-4A24-BFE1-0E3368AFBF16Q45983566-50E4BAC2-C5E0-4D42-B799-EFC505AAA30BQ46514864-7F57D16D-9F3E-4334-A984-EDD6F3FF5D5DQ46903179-C48ADBB0-1A4C-4994-8987-BB8DD93C618EQ48783920-7ED12117-F8A9-4A60-AB48-FB6563FC5D6AQ48920002-320BFAEC-EAD2-4354-A2F0-38C3143FCFCAQ48961918-C2FFF9F4-A8FB-4131-B331-B93DF9D653C4Q50279579-03DD6926-D41B-4F4E-86DA-934532A3A07DQ54935894-7EA75FDB-D030-43D9-BB8B-E3F5DDDDA155Q55245469-5DB534AE-C58C-4739-9BD3-A0A192053296
P2860
Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Brainstem neurodegeneration co ...... proton spectroscopy MR study.
@en
type
label
Brainstem neurodegeneration co ...... proton spectroscopy MR study.
@en
prefLabel
Brainstem neurodegeneration co ...... proton spectroscopy MR study.
@en
P2093
P356
P1433
P1476
Brainstem neurodegeneration co ...... proton spectroscopy MR study.
@en
P2093
Cosottini M
De Grandis D
Della Nave R
Ginestroni A
Guerrini L
Mascalchi M
P304
P356
10.1093/BRAIN/AWH201
P407
P577
2004-07-07T00:00:00Z